- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Sinclair Research Center
Sinclair Research Center is listed as a mid sized business research supplier in the Scientist.com network, with 1 site in 1 country and 2 service areas.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Biomarkers
- Anatomic Pathology Do macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
- Flow Cytometry Identify fluorescently-labeled cells or physically separate cells from a larger population using biomarkers.
- Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
- Immunoassays Create antibody-based assays for the identification and quantification of specific antigens.
Cell Culture and Characterization
- Chromosomal Characterization Establish karyotype/chromosome profile by cytogenetic analysis of cell preparation.
- Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
Chemical and Compound Analysis
- GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
- GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
- Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
- Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
Chemical and Compound Testing
- Clinical Pathology Diagnose disease based on the laboratory analysis of bodily fluids, such as blood, urine and tissues.
- Nutritional Testing Analyze food safety, vendor specifications, foreign substance identification processes and nutritional labeling.
- Product Testing Ensure product quality standards are met.
Show all 158 services
Clinical Trials
- Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
Developmental and Reproductive Toxicology (DART)
- Bioelectronics Evaluate an application (e.g. device) that integrates biological materials and micro and nano-electronics.
- Embryo-Fetal Development (EFD) Study (Segment II) Test drug candidate in Segment II toxicology services.
- Fertility and Embryonic Development Study (Segment I) Test drug candidate in Segment I toxicology services.
- Juvenile Toxicity Study - Dog / Canine Conduct a study to determine the differences in toxicity between immature and mature systems in dogs.
- Juvenile Toxicity Study - Other Species Conduct a study to determine the differences in toxicity between immature and mature systems in other species.
- Reproductive Toxicology Study adverse sexual function and fertility and examine teratogenicity of compounds.
Disease Models
- Acne Models Measure therapeutic endpoints in animal models of acne.
- Arthritis Models Measure therapeutic endpoints in animal models of arthritis.
- Atopic Dermatitis Models Measure therapeutic endpoints in animal models of atopic dermatitis.
- Atrial Arrhythmias Models Measure therapeutic endpoints in animal models of atrial arrhythmias.
- Bone Models Measure therapeutic endpoints in animal models of bone disorders.
- Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
Show all 32 in Disease Models
- Cartilage Repair Models Measure therapeutic endpoints in animal models of cartilage repair.
- Cataract Models Measure therapeutic endpoints in animal models of cataracts.
- Dermatology Models Measure therapeutic endpoints in animal models of dermatological disorders.
- Diabetic Retinopathy Models Assess therapeutic efficacy of drug candidates in diabetic retinopathy models of disease.
- Dry Eye Models Measure therapeutic endpoints such as tear induction, TBUT, Schirmer strips (tear volume) and cornea staining.
- In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
- Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
- Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
- Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
- Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
- LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
- Macular Degeneration Models Use a single animal species to create one or more models for eye disease.
- Non Obese Diabetic Mice Use a single animal species to create one or more disease models for diabetes.
- Obese Mice Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
- Obese Primates Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
- Ocular Inflammation Models Measure ocular inflammation in models of eye disorders such as uveitis and keratitis.
- Ophthalmic Models Test drug candidates in glaucoma, macular degeneration, keratitis, uveitis and CMV retinitis models.
- Osteoarthritic Pain Models Measure therapeutic endpoints in animal models of osteoarthritic pain.
- Osteoarthritis Models Measure therapeutic endpoints in animal models of osteoarthritis.
- Osteoporosis Models Measure therapeutic endpoints in animal models of osteoporosis.
- Pain Models Test therapeutic efficacy of drug candidate in pain model.
- Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
- Skin Graft Models Measure therapeutic endpoints in animal models of skin grafts.
- Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
- Tissue Rejection Models Measure therapeutic endpoints in animal models of tissue rejection.
- Wound Healing Models Measure therapeutic endpoints in animal models of wound healing.
Effectiveness
- Bioequivalence Studies for Veterinary Drugs Assess the expected biological equivalence of two proprietary preparations of a veterinary drug.
- Field Dose Confirmation Studies Conduct an in vivo study to confirm the effectiveness of a selected drug dose in actual field conditions.
Food Safety & Regulations
- USDA Certification Ensure compliance with USDA regulations by an accredited certifying agent for quality assurance and brand marketing.
General in vivo Toxicology
- Dose Range Finding Study - Dog /Canine Conduct a study to determine the dose range of your compound in dogs/canines.
- Dose Range Finding Study - Mouse Conduct a study to determine the dose range of your compound in mice.
- Dose Range Finding Study - Other Species Conduct a study to determine the dose range of your compound in other species.
- Dose Range Finding Study - Rat Conduct a study to determine the dose range of your compound in rats.
- General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
- IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
Show all 18 in General in vivo Toxicology
- Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
- Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
- Repeat Dose Toxicity Study - Dog / Canine Conduct a repeat dose study in dogs to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Toxicity Study - Monkey / Non-human Primate Conduct a repeat dose study in monkey/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Toxicity Study - Other Species Conduct a repeat dose study in other species to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
- Single Dose Acute Toxicity Study - Dog / Canine Conduct a single dose study in Dogs and Canines to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Toxicity Study - Monkey / Non-human Primate Conduct a single dose study in Monkeys and Non-human Primates to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.
- Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
- Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.
In Vitro Pharmacology
- In Vitro Bone Models Measure osteoclast activity and bone formation in human or rat osteoclasts.
In Vitro Toxicology
- Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
- Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.
- Cytotoxicity Test for effects on cell viability and proliferation
In Vivo ADME
- Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
- Chronic Bile Duct Cannulation (BDC) Study - Dog / Canine Conduct a bile duct cannulation (BDC) study in dogs/canines to support the absorption, distribution, metabolism and excretion profiling of your compound.
- Chronic Bile Duct Cannulation (BDC) Study - Monkey / Non-human Primate Conduct a bile duct cannulation (BDC) study in monkeys/non-human primates to support the absorption, distribution, metabolism and excretion profiling of your compound.
- Chronic Bile Duct Cannulation (BDC) Study - Other Species Conduct a bile duct cannulation (BDC) study in other species to support the absorption, distribution, metabolism and excretion profiling of your compound.
- Chronic Bile Duct Cannulation (BDC) Study - Rat Conduct a bile duct cannulation (BDC) study in rats to support the absorption, distribution, metabolism and excretion profiling of your compound.
In Vivo Pharmacokinetics
- In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
- Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
- Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
- Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
- Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
- Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
Medical Communications
- Toxicology Reports Create pre-clinical toxicology reports.
Model Development
- Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
- Juvenile Toxicology Assess developmental and reproductive defects due to neurobehavioral, skeletal and muscle growth effects.
- Non-Human Primate Models Use a single animal species to create one or more disease models.
- Standard Models Create new animal disease models or modify existing models to study specific diseases, side-effects or symptoms.
- Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
Neurotoxicology
- Single Dose Acute Neurotoxicity Study - Other Species Conduct a single dose study in other species to determine the neurotoxicty of your compound.
Non-Human Biospecimen
- Monkey / Non-Human Primate / NHP Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
- Pig / Minipig / Porcine Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
- Pig / Minipig / Porcine Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
- Pig / Minipig / Porcine Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.
Other Specialty Toxicology
- Cutaneous Phototoxicity Study - Guinea Pig Conduct a study in guinea pigs to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
- Cutaneous Phototoxicity Study - Other Species Conduct a study in other species to determine if a toxic response is elicited after the initial exposure to your compound and subsequent exposure to light.
- Ocular Phototoxicity Study - Other Species Conduct a study to determine the extent to which your compound is capable of producing phototoxic side effects in ocular tissues of other species.
- Ototoxicity Study - Monkey / Non-human Primate Conduct a study in monkeys/non-human primates to determine the potential for your compound to cause hearing loss.
- Ototoxicity Study - Other Species Conduct a study in other species to determine the potential for your compound to cause hearing loss.
- Phototoxicity Determine whether drug treatment causes light-activated toxic effects.
Protein Sciences
- ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
REACH Services
- Hazard, Exposure and Risk Assessment Evaluate the known hazard of a test compound in conjunction with the expected quantity and frequency of exposure.
Safety Pharmacology
- Abuse and Dependence Liability Testing Determine the abuse or dependence potential of a therapeutic.
- Immunotoxicity Measure effects of drugs on immune function, allergic hypersensitization and autoimmune toxicity.
- Implanted Telemetry Study - Dog / Canine Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in dogs/canines.
- Implanted Telemetry Study - Other Species Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in other species.
- Jacketed External Telemetry (JET) Study - Minipig Conduct a study that allows the continuous collection of cardiovascular data following dosing of your compound in minipigs.
- Respiratory Toxicology Assess difficulty breathing, altered respiration, blood gas changes and blood pH issues due to adverse reactions.
Show all 11 in Safety Pharmacology
- Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
- Safety Pharmacology Latin Square Study - Dog / Canine Conduct a safety pharmacology study with a Latin square design in dogs/canines.
- Safety Pharmacology Latin Square Study - Other Species Conduct a safety pharmacology study with a Latin square design in other species.
- Safety Pharmacology Study with Functional Observational Batteries (FOBs) - Other Species Conduct a safety pharmacology study with functional oberservational batteries in other species.
- Telemetry Use implantable or external devices to study physiological parameters in model organisms
Specialty Dosing Routes
- Dermal Toxicology Assess toxicity in rodent dermal testing models.
- Intra-Articular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered directly to the joint.
- Intra-Auricular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the ear.
- Intrathecal/Intraspinal Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the intrathecal space.
- Intravitreal Toxicity and/or Toxicokinetic Study - Minipig Conduct an intravitreal ocular toxicity study in minipigs to determine the toxicity and toxicokinetic behavior of your compound.
- Ophthalmologic Toxicology Measure toxicity by microscopy, vitrectomy, tonometry, electroretionography and corneal colorimetry.
Show all 35 in Specialty Dosing Routes
- Repeat Dose Intranasal Study - Dog / Canine Conduct a repeat dose intranasal study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intranasal Study - Monkey / Non-human Primate Conduct a repeat dose intranasal study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intranasal Study - Mouse Conduct a repeat dose intranasal study in mice to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intranasal Study - Other Species Conduct a repeat dose intranasal study in other species to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intranasal Study - Rat Conduct a repeat dose intranasal study in rats to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intravenous Infusion Study - Dog / Canine Conduct a repeat dose intravenous infusion study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intravenous Infusion Study - Monkey / Non-human Primate Conduct a repeat dose intravenous infusion study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intravenous Infusion Study - Other Species Conduct a repeat dose intravenous infusion study in other species to determine the toxicity and toxicokinetic behavior of your compound.
- Repeat Dose Intravenous Infusion Study - Rats Conduct a repeat dose intravenous infusion study in rats to determine the toxicity and toxicokinetic behavior of your compound.
- Single Dose Acute Intranasal Study - Dog / Canine Conduct a single dose intranasal study in dogs/canines to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intranasal Study - Mouse Conduct a single dose intranasal study in mice to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intranasal Study - Other Species Conduct a single dose intranasal study in other species to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intranasal Study - Rat Conduct a single dose intranasal study in rats to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intravenous Infusion Study - Dog / Canine Conduct a single dose intravenous infusion study in dogs/canines to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intravenous Infusion Study - Other Species Conduct a single dose intravenous infusion study in other species to determine the toxicokinetic behavior of your compound.
- Single Dose Acute Intravenous Infusion Study - Rats Conduct a single dose intravenous infusion study in rats to determine the toxicokinetic behavior of your compound.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to dogs/canines.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Minipig Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to minipigs.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Monkeys/Non-human Primates Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to monkeys/non-human primates.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Mouse Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to mice.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Other Species Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to other species.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Rabbit Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rabbits.
- Topical Dermal Toxicity and/or Toxicokinetic Study - Rat Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rats.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Dog / Canine Conduct a topical ocular toxicity study in dogs/canines to determine the toxicity and toxicokinetic behavior of your compound.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Minipig Conduct a topical ocular toxicity study in minipigs to determine the toxicity and toxicokinetic behavior of your compound.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Monkey / Non-human Primate Conduct a topical ocular toxicity study in monkeys/non-human primates to determine the toxicity and toxicokinetic behavior of your compound.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Mouse Conduct a topical ocular toxicity study in mice to determine the toxicity and toxicokinetic behavior of your compound.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Rabbit, Non-pigmented (New Zealand White; NZW) Conduct a topical ocular toxicity study in non-pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
- Topical Ocular Toxicity and/or Toxicokinetic Study - Rabbit, Pigmented (Dutch Belted, New Zealand Red) Conduct a topical ocular toxicity study in pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
Target Animal and Human Food Safety
- Target Animal Safety (TAS) Studies Evaluate potential harmful effects associated with the use of a new animal drug in a controlled setting.
- Tolerance Studies Conduct tolerance studies on target animals of veterinary products.
- Toxicity Test for Veterinary Drugs Use the drug at 10X the recommended dose for 3X the recommended duration to evaluate its safety.
- Toxicokinetic Analysis Determine the drug concentration at which off-target or toxic effects occur.
Other services
- New Request
Service areas:
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
Sinclair Research Center (Sinclair) is a biomedical research facility located in new facilities near Columbia, Missouri, offering the full range of preclinical (nonclinical) research services to the animal and human health industries. From discovery to IND/INAD submission and beyond, Sinclair divisions can conduct all phases of nonclinical programs, including DMPK, surgical service, device and test article efficacy assessment, safety pharmacology, general toxicology, and specialized toxicology. Originally located on 543 acres in Columbia, Missouri, Sinclair was formed in 1965...
Show the full description
Sinclair Research Center (Sinclair) is a biomedical research facility located in new facilities near Columbia, Missouri, offering the full range of preclinical (nonclinical) research services to the animal and human health industries. From discovery to IND/INAD submission and beyond, Sinclair divisions can conduct all phases of nonclinical programs, including DMPK, surgical service, device and test article efficacy assessment, safety pharmacology, general toxicology, and specialized toxicology.
Originally located on 543 acres in Columbia, Missouri, Sinclair was formed in 1965 by the University of Missouri (UMC) and originally named the Sinclair Comparative Medical Research Farm (SCMRF). Its primary function was to provide laboratory animal research support for the University's Environmental Health Surveillance Center (EHSC) and the Environmental Trace Substance Research Center (ETSRC). These three entities collaborated to monitor for epidemiological evidences of environmental related illnesses (EHSC), samples were analyzed to detect trace amounts of substances which could be related to illnesses (ETSRC), and laboratory animal models were used to test the hypotheses (SCMRF). This concept was remarkably farsighted and it remains valid today.
Through the years, Sinclair's role expanded and became a resource for a wide variety of animal and human health related research and became deeply involved in the development and use of animal models. Its original financial support was primarily from the University of Missouri and research grant funds that it attracted. The private sector quickly realized the unique resource of Sinclair and became the main source of funding support during the early 1990's. Concurrently with the declining funding from the University, dedicated professionals privatized Sinclair on March 1, 1994 as a successful contract research organization (CRO) and animal production facility.
Sinclair continues its mission of providing high quality research and producing purpose bred animals. Since privatization, constant upgrading of personnel, facilities and equipment have resulted in an efficient, competitive, GLP-compliant research center which maintains AAALAC accreditation, first obtained the year after privatization. Sinclair has also contributed to the development of several animal models and acquired a domestic short hair-cat colony and several new herds of miniature swine including the Charles River miniature swine colonies.
To accommodate the growth of Sinclair and to improve the quality of the research and production facilities, Sinclair purchased 200-acres near Columbia and built a state-of-the-art research and animal production complex that has more than twice the capacity of the original UMC site. Sinclair moved operations to the new facilities in the fall of 2004 and continues to grow. Facilities now include more than 250,000 sq ft of buildings on 433 acres. Sinclair also operates the Maine Yucatan Miniature Swine production facility acquired from Charles River Laboratories, and has instituted improvements and expansions in that facility as well.
Sinclair is committed to efficiency, confidentiality and rapid, accurate service. Our desire is to work closely with our clients to achieve long-term mutually beneficial relationships.
Preclinical (Nonclinical) Research Service Offerings
Sinclair offers a variety of preclinical (nonclinical) research services to the human pharmaceutical and medical device, animal health, and consumer product industries. Programs include efficacy/pharmacodynamics, DMPK, toxicology, and surgical services. All standard routes of administration are offered. We can support drug and device research from discovery through initial regulatory submission. We understand that our clients’ study needs sometimes don’t fit into standard study designs. We encourage you to contact us to discuss unique study programs to accomplish your product development objectives.
Research Staff
Sinclair has a friendly, experienced, and motivated veterinary and research staff who provide you with quality study execution, excellent communication, and timely reporting. Experienced study directors and principal investigators, assisted by support staff, manage studies vertically, maintaining full control over your study. Complementing the research personnel are competent veterinary staff members who participate in the study conducting procedures, collecting samples, and maintaining animal health. Qualified laboratory animal personnel provide husbandry and care for the animals. A full training program is in place at Sinclair and all personnel have current training records.
Regulatory Compliance and Quality Assurance
Sinclair complies with a number of agencies. We are USDA licensed as a breeder (43-A-2499) and research facility (43-R-0109). We are AAALAC accredited and have maintained this accreditation since 1995. The animal care and veterinary program is in compliance with the Guide for the Care and Use of Laboratory Animals. Sinclair also has an Assurance Statement filed with PHS.
Sinclair is fully GLP compliant and our personnel have many years of GLP experience. Sinclair has an independent Quality Assurance Unit (QAU) that audits the facility, protocols, in-life critical phases, raw data, and reports for GLP studies. Sinclair is inspected by the FDA on an ongoing basis. Inspections in the spring of 2002, spring of 2004, and late fall of 2005 were all classified as NAI (no objectionable conditions or practices were found during the inspection), and no 483s were issued.
Alliance Partner Services
Sinclair collaborates with several centers of expertise which provide complementary services to the research program, such as bioanalytical, and histopathology. Furthermore, Sinclair's clients have access to a large number of well known expert consultants due to Sinclair's advantageous location near the University of Missouri-Columbia's College of Veterinary Medicine, Health Center and Teaching Hospital, and the Ellis Fischel Cancer Hospital.
- Professional associations
- AAPS, SOT
- Website
- www.sinclairresearch.com
Work with Sinclair Research Center on Scientist.com
For prices, more details, or to contact Sinclair Research Center, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.